Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 26, 2017
Pharmacy Choice - News - Generic Drugs - May 26, 2017

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 40     Next >>     Go To Page:

5/26/17 - Cosunter Pharmaceutical Viread Generic Drug Nodded
FUJIAN, May 26, SinoCast Reporters noticed that Fujian Cosunter Pharmaceutical Co., Ltd. has gotten registration approval for making generic drug of Viread curing HBV, since existing HBV drugs are facing risk for declining sales volume, dragging down net profit. In 2016, Cosunter Pharmaceutical harvested operating revenue climbing 1.28% from a ye
5/26/17 - FDA Panel Recommends Approval Of Epoetin Alfa Biosimilar Across All Indications
NEW YORK CITY- Pfizer Inc. said that the United States Food and Drug Administration Oncologic Drugs Advisory Committee recommended to approve Company's proposed epoetin alfa biosimilar across all indications. This marks the first time a biosimilar erythropoiesis-stimulating agent has been recommended for approval by a U.S. FDA Advisory Committee.
5/26/17 - NINLARO Capsules Now Available for the Treatment of Multiple Myeloma in Japan
Release date- 24052017- Osaka, Japan- Takeda Pharmaceutical Company Limited today announced that NINLARO capsules are now available in Japan. NINLARO is the first oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone, for which Takeda has obtained the New Drug Application Approval for the treatment of patients with
5/26/17 - Pharmaceutical Packaging Equipment Market to Reach $8.24 Billion by 2022 - Driven by Growth in Funding For Generics & Biopharmaceutical Research - Research and Markets
Research and Markets has announced the addition of the "Pharmaceutical Packaging Equipment Market- Global Forecast to 2022" report to their offering. The global pharmaceutical packaging equipment market is projected to reach approximately USD 8.24 Billion by 2022 at an approximate CAGR of 6.8% during the forecast period. The growth of the pharmaceu
5/26/17 - Studies in the Area of Social and Administrative Pharmacy Reported from Faculty of Pharmacy (Translation and validation of the Arabic version of...
Studies in the Area of Social and Administrative Pharmacy Reported from Faculty of Pharmacy. By a News Reporter-Staff News Editor at Drug Week Data detailed on Drugs and Therapies- Social and Administrative Pharmacy have been presented. According to news reporting from Irbid, Jordan, by NewsRx journalists, research stated, "Generic drugs are cons
5/26/17 - Switzerlands Novartis to lift investment in medical research in SA [Syrian Arab News Agency]
Swiss drug manufacturer Novartis has signed a memorandum of agreement with the South African Medical Research Council and the department of science and technology that paves the way for the company to increase its investments in local medical research. In addition to its innovative drug business, it owns generic drug maker Sandoz and eye care unit
5/26/17 - Why biosimilars are changing the pharmaceutical industry
We caught up with Celltrion Healthcare's Ho-ung Kim to find out how biosimilars cut costs, increase access to medicine and are ultimately changing the industry?
5/25/17 - Eatontown drug execs will tell all in price-fixing case [Asbury Park Press, N.J.]
May 24 Two former drug company executives from Monmouth County reached a settlement and will cooperate with investigators in a price-fixing case against some of the nation's biggest generic drug makers, authorities said Wednesday. Jeffery Glazer and Jason Malek, who led Heritage Pharmaceuticals in Eatontown, agreed to provide documents, testimony
5/25/17 - FDA Advisory Committee Recommends Approval of Pfizer's Proposed Biosimilar to Epogen/Procrit Across All Indications
Pfizer Inc. today announced the United States Food and Drug Administration Oncologic Drugs Advisory Committee recommended approval of the Company s proposed epoetin alfa biosimilar across all indications. The Committee s recommendation reinforces the potential value of biosimilars in expanding access to additional high-quality treatment op
5/25/17 - Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR by Par Pharmaceutical [Tehran Times (Iran)]
-Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that its United States marketing partner, Par Pharmaceutical Inc., has launched the 10 and 20 mg strengthsof its generic...
5/25/17 - Julphar's Board of Directors Meeting Held on May 18th, 2017 [Mid-East.Info]
By 2020, the Emirati company aims to reach more than AED 2 billion sales and rank among the top 3 pharmaceutical companies in the UAE and in Saudi Arabia. Despite challenging market conditions and the overall regional situation that are impacting our industry, Julphar is consolidating its market share for the first Quarter, said Jerome Carle,
5/25/17 - Orchid Pharma gets US FDA approval for Aripiprazole tablet [Sudan Tribune]
Orchid Pharma Limited, in its BSE filing on Wednesday, announced that it has received Abbreviated New Drug Application approval from US FDA for Aripiprazole Tablets USP, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg. Orchid Pharma Limited was trading at Rs 30.25, up by Rs 0.60 or 2.02%, on Wednesday, on the BSE. Orchid Pharma Ltd is currently trading
5/25/17 - States Have Reached Settlements, Cooperation Agreements With Two Former Drug Company Executives
New Jersey Attorney General Christopher S. Porrino issued the following news release:. Two former executives of a New Jersey- based generic pharmaceutical manufacturing company have entered into settlement and cooperation agreements with 41 states including New Jersey that are investigating what they allege is widespread anti-competitive activi
5/25/17 - Virginia, 40 Other States Reach Settlements, Cooperation Agreements with Two Former Executives in Generic Drug Multistate Investigation
Attorney General Mark R. Herring announced today that two former executives of a New Jersey- based generic pharmaceutical manufacturer have entered into settlement and cooperation agreements with 40 states that are investigating what they allege is widespread anticompetitive activity in the generic drug industry that has led to higher prices for...
5/24/17 - Dramatic increase in patient access across Europe [Sudan Tribune]
Medicines for Europe acknowledges the role of the European Commission and its partnership with QuintilesIMS in pursuing the dialogue and close monitoring of the unfolding competition in the biologics market. The new report on The Impact of Biosimilar Competition in Europe highlights the visible benefits of biosimilar competition to increase patient
5/24/17 - Findings from Pfizer Reveals New Findings on Follicular Lymphoma (Rituximab in the treatment of follicular lymphoma: the future of biosimilars in the...
By a News Reporter-Staff News Editor at Biotech Week New research on Oncology- Follicular Lymphoma is the subject of a report. According to news reporting from New York City, New York, by NewsRx journalists, research stated, "Follicular lymphoma is the second most common type of non-Hodgkin's lymphoma. The news correspondents obtained a quote fro
5/24/17 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 18298) - Meeting
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting of the Oncologic Drugs Advisory Committee to discuss biologics license application 125545, for a proposed biosimilar to Amgen Inc.' s Epogen/Procrit, submitted by Hospira Inc., a Pfizer company, for the treatment of anemia. LOCATION: FDA White Oak Campus, 1090
5/24/17 - Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR by Par Pharmaceutical
Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that its United States marketing partner, Par Pharmaceutical Inc., has launched the 10 and 20 mg strengths of its generic.
5/24/17 - Orchid Pharma gets US FDA approval for Aripiprazole tablet [India Infoline News Service]
Orchid Pharma Limited, in its BSE filing on Wednesday, announced that it has received Abbreviated New Drug Application approval from US FDA for Aripiprazole Tablets USP, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg. Orchid Pharma Limited, in its BSE filing on Wednesday, announced that it has received Abbreviated New Drug Application approval from US
5/24/17 - Report Summarizes Antineoplastic Monoclonal Antibodies Study Findings from Amgen (A randomized, single-blind, single-dose study evaluating the...
By a News Reporter-Staff News Editor at Biotech Week Researchers detail new data in Drugs and Therapies- Antineoplastic Monoclonal Antibodies. According to news reporting originating in Thousand Oaks, California, by NewsRx journalists, research stated, "This study compared the pharmacokinetic profiles of the proposed biosimilar ABP 980 and trastu
5/24/17 - Research Results from University Hospital Ulm Update Knowledge of Biologics (An introduction to biosimilar cancer therapeutics: definitions,...
By a News Reporter-Staff News Editor at Biotech Week New research on Biotechnology- Biologics is the subject of a report. According to news reporting originating from Ulm, Germany, by NewsRx correspondents, research stated, "Monoclonal antibodies and other biologic drugs play important roles in the treatment of various hematological malignancies
5/24/17 - Sun Pharma Announces US FDA Filing Acceptance of Biologics License Application (BLA) For Tildrakizumab
The FDA filing acceptance follows acceptance of the regulatory filing of tildrakizumab by the European Medicines Agency in March 2017. The acceptance of the regulatory filing by the U.S. FDA marks a significant milestone as we seek to advance for tildrakizumab as a potential new treatment option for people who continue to struggle everyday with the
5/23/17 - Biosimilar medicines: Dramatic increase in patient access across Europe
Biosimilar medicines have dramatically increased patient access to biological medicines, according to the recently published QuintilesIMS report...
5/23/17 - Biosimilars Market is expected to reach USD 10.90 billion by 2021
Biosimilars Market by Product, Manufacturing& Application- Global Forecast To 2021. The global biosimilars market is expected to reach USD 10.90 billion by 2021 from USD 3.39 billion in 2016, at a CAGR of 26.3%. The biosimilars market is broadly classified into product, manufacturing type, application, and region. On the basis of product, the biosi
5/23/17 - Miraca Life Sciences Again Expands Therapeutic Drug Monitoring with Addition of First Biosimilar Inflectra
Miraca Life Sciences, the largest U.S. independent anatomic pathology laboratory, has further expanded its InformTx? therapeutic drug monitoring capabilities with the addition of testing for Inflectra , which is the first biosimilar drug in the test offering. Since launching InformTx in June 2016, Miraca Life Sciences has expanded the service f
Articles(s): 1 - 25 of 40     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415